DK2266596T3 - Farmaceutisk sammensætning og fremgangsmåde til fremstilling deraf - Google Patents
Farmaceutisk sammensætning og fremgangsmåde til fremstilling derafInfo
- Publication number
- DK2266596T3 DK2266596T3 DK08767349.7T DK08767349T DK2266596T3 DK 2266596 T3 DK2266596 T3 DK 2266596T3 DK 08767349 T DK08767349 T DK 08767349T DK 2266596 T3 DK2266596 T3 DK 2266596T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA200803496A UA90013C2 (ru) | 2008-03-19 | 2008-03-19 | Фармацевтическая композиция, содержащая инсулин, и способ его получения |
PCT/UA2008/000019 WO2009116960A1 (ru) | 2008-03-19 | 2008-03-25 | Фармацевтическая композиция и способ её получения |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2266596T3 true DK2266596T3 (da) | 2014-10-13 |
Family
ID=41091167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08767349.7T DK2266596T3 (da) | 2008-03-19 | 2008-03-25 | Farmaceutisk sammensætning og fremgangsmåde til fremstilling deraf |
Country Status (6)
Country | Link |
---|---|
US (1) | US20110064818A1 (da) |
EP (1) | EP2266596B1 (da) |
CA (1) | CA2718915A1 (da) |
DK (1) | DK2266596T3 (da) |
UA (1) | UA90013C2 (da) |
WO (1) | WO2009116960A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102240042B1 (ko) * | 2012-05-03 | 2021-04-14 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 상기도 감염 치료용 폴리이노신산-폴리사이티딜산(폴리 (i:c)) 제형 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554388A (en) * | 1989-02-25 | 1996-09-10 | Danbiosyst Uk Limited | Systemic drug delivery compositions comprising a polycationi substance |
RU2175556C2 (ru) | 1994-03-07 | 2001-11-10 | Инхейл Терапьютик Системз | Способы и композиции для легочной доставки инсулина |
RU2066551C1 (ru) * | 1994-03-23 | 1996-09-20 | Институт нефтехимического синтеза РАН | Способ получения инсулинсодержащих полимерных гидрогелей |
CZ92497A3 (en) * | 1994-09-29 | 1997-08-13 | Andaris Ltd | Micro-particles of water soluble material intended for use in therapy or diagnosis, inhaling apparatus containing such particles and application of a therapeutical agent |
US6201072B1 (en) | 1997-10-03 | 2001-03-13 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
UA24452C2 (uk) | 1998-01-09 | 2003-08-15 | Закритоє Акціонєрноє Общество "Фосфосорб" | Рекомбінантна плазмідна днк, що кодує препроінсулін людини і штам escherichia coli xl1 - blue / p insr- продуцент препроінсуліну |
RU2148642C1 (ru) | 1998-12-23 | 2000-05-10 | ЗАО "Научно-исследовательский институт АДЖИНОМОТО-Генетика" (ЗАО "АГРИ") | Фрагмент днк rhtc, кодирующий синтез белка rhtc, придающего повышенную устойчивость к l-треонину бактериям escherichia coli, и способ получения l-аминокислоты |
DE19940794A1 (de) | 1999-08-27 | 2001-03-01 | Lohmann Therapie Syst Lts | Pharmazeutische Zubereitung |
JP2004515527A (ja) | 2000-12-13 | 2004-05-27 | メルクル・ゲーエムベーハー | 放出特性改良微粒子およびその製造方法 |
KR20030027108A (ko) | 2001-07-05 | 2003-04-03 | 트렌스레셔널 리서치 가부시키가이샤 | 인슐린의 경비 투여용 조성물 |
FI116625B (fi) * | 2004-01-28 | 2006-01-13 | Macrocrystal Oy | Menetelmä proteiinien kiteyttämiseksi hiilihydraattirunkoisilla polymeereillä |
ES2277743B2 (es) * | 2005-06-02 | 2008-12-16 | Universidade De Santiago De Compostela | Nanoparticulas que comprenden quitosano y ciclodextrina. |
BRPI0716157A2 (pt) * | 2006-09-05 | 2013-09-17 | Ct Brasileiro De Pesquisa Fisica Cbpf | processo para produÇço microcÁpsulas dotadas de propriedades magnÉticas, produto obtido e mÉtodo para a liberaÇço controlada de substÂncias ativas |
RU2316339C1 (ru) | 2006-09-13 | 2008-02-10 | Общество С Ограниченной Ответственностью "Концерн О3" | Способ получения препарата инсулина для перорального применения |
-
2008
- 2008-03-19 UA UAA200803496A patent/UA90013C2/ru unknown
- 2008-03-25 WO PCT/UA2008/000019 patent/WO2009116960A1/ru active Application Filing
- 2008-03-25 CA CA2718915A patent/CA2718915A1/en not_active Abandoned
- 2008-03-25 EP EP08767349.7A patent/EP2266596B1/en active Active
- 2008-03-25 DK DK08767349.7T patent/DK2266596T3/da active
-
2010
- 2010-09-16 US US12/883,984 patent/US20110064818A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2266596A4 (en) | 2013-06-05 |
WO2009116960A1 (ru) | 2009-09-24 |
US20110064818A1 (en) | 2011-03-17 |
UA90013C2 (ru) | 2010-03-25 |
EP2266596A1 (en) | 2010-12-29 |
CA2718915A1 (en) | 2009-09-24 |
EP2266596B1 (en) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1250313A1 (zh) | 穩定的藥物組合物和使用所述組合物的方法 | |
DK3795573T3 (da) | Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf | |
DK3345625T3 (da) | Farmaceutisk sammensætning og indgivelser deraf | |
DK2419670T3 (da) | Leveringsmetode og sammensætninger | |
DK2475372T4 (da) | Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse | |
DK2493474T3 (da) | Fremgangsmåder og sammensætninger til vedvarende afgivelse af lægemidler | |
DK2273975T3 (da) | Farmaceutiske opløsninger, fremgangsmåde til fremstilling og terapeutiske anvendelser | |
DK2322221T3 (da) | Farmaceutisk sammensætning til behandling og forebyggelse af cancer | |
DK2149307T3 (da) | Fermenteret vallesammensætning og fremgangsmåde til fremstilling deraf | |
DK2244783T3 (da) | Flygtige anæstetiske sammensætninger og fremgangsmåder til anvendelse | |
DK2413913T3 (da) | Farmaceutiske formuleringer omfattende nitrocatecholderivater og fremgangsmåder til fremstilling deraf | |
DK2254590T3 (da) | Fremgangsmåder og præparater til oral administration af insulin | |
DK2320740T3 (da) | Farmaceutiske sammensætninger af clevidipin og fremgangsmåder tilfremstilling af koncentrationer deraf med lave urenhedsgrader | |
BRPI0907077A2 (pt) | métodos e composições para administração oral de proteínas | |
BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
DK2069467T3 (da) | Adskillende sammensætninger og fremgangsmåder til anvendelse | |
DK2475649T3 (da) | Indenonderivat og farmaceutisk sammensætning omfattende samme | |
DK2114393T3 (da) | Farmaceutiske sammensætninger omfattende trigonellin og 4-hydroxyisoleucin og fremgangsmåde hertil | |
DK2307445T3 (da) | Fremgangsmåde til fremstilling af caspofungin og mellemforbindelser heraf | |
BRPI0921507A2 (pt) | composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo | |
EP2345416A4 (en) | PHARMACEUTICAL COMPOSITION FOR CLEANING VENES AND MANUFACTURING METHOD THEREFOR | |
DK2172207T3 (da) | Farmaceutisk sammensætning til behandling af diabetes og fremgangsmåde til fremstilling heraf | |
DK2190665T3 (da) | Kompositorgan og fremgangsmåde til dets fremstilling | |
DK2334596T3 (da) | Ferriphosphatbaseret sammensætning og anvendelse heraf | |
DK2588097T3 (da) | Farmaceutiske sammensætninger omfattende paracetamol og fremgangsmåde til fremstilling af samme |